We’re providing solutions, which enable greater efficiency of pre-clinical scanning and monitoring of therapeutic interventions

69.5% of the effort of bringing new drugs to launch is typically in the pre-clinical and clinical trial phases.

Discover our technology

More on our pre-clinical hardware Learn about XV LVAS

4DMedical’s XV Technology is transforming pharma and medtech productivity

Minimising risk for globally prominent B2B customers – improving measurement of drug efficacy, and prioritising pipeline assets and the most promising technologies with business confidence gained from clearer insights.

Commercial contract signed with Novartis

4DMedical announced the signing of a commercial contract with Novartis.

Under the terms of the agreement, XV Ventilation Reports will be provided to Novartis on a commercial basis…

XV LVAS Ventilation report

The XV Technology Lung Ventilation Analysis Software provides a non-invasive way of understanding regional lung function during active breathing. It enables highly-detailed colour-coded maps and other health metrics for clearer insights into lung health.

Contact us

AU: + 61 3 9545 5940 |
US: +1 818 794 6467